Skip to content

Emerald Health Therapeutics Inc.

company.status.inactive

CIK 1768225fmd_0X7SZNT7P6NZYNMK21B36B8GBCManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2017 to Dec 31, 2019, 9 periods

Latest annual · FY2019

Millions
Total revenues
22
Gross profit
(14)
Operating income
(51)
Net income
111
Free cash flow
(49)

Latest quarter · Q4 FY2019

Millions
Total revenues
5
Gross profit
(7)
Operating income
(13)
Net income
90
Free cash flow
(4)
Open Financials

Emerald Health Therapeutics Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2019FY2018ChangeSource
RevenueCA$22.3 millionCA$2.1 million+958.5%20-F 2020-06-10 · proof
Gross profit-CA$14.5 million-CA$3.1 million20-F 2020-06-10 · proof
Operating income-CA$51 million-CA$37.3 million20-F 2020-06-10 · proof
Net incomeCA$111.1 millionCA$30.6 million+263.5%20-F 2020-06-10 · proof
Cash from operating activities-CA$24.8 million-CA$29.1 million20-F 2020-06-10 · proof
Free cash flow-CA$48.9 million-CA$46.3 million20-F 2020-06-10 · proof
Total assetsCA$156.6 millionCA$207 million-24.3%20-F 2020-06-10 · proof
Total liabilitiesCA$53.5 millionCA$36.5 million+46.6%20-F 2020-06-10 · proof
Cash and cash equivalentsCA$2.5 millionCA$36 million-93%20-F 2020-06-10 · proof
What was Emerald Health Therapeutics Inc.'s revenue in fiscal 2019?
Emerald Health Therapeutics Inc. reported revenue of CA$22.3 million for fiscal 2019 (the year ended Dec 31, 2019), against CA$2.1 million the year before (+958.5%). Source: the 20-F filed with the SEC on Jun 10, 2020. SEC
What was Emerald Health Therapeutics Inc.'s gross profit in fiscal 2019?
Emerald Health Therapeutics Inc. reported gross profit of -CA$14.5 million for fiscal 2019 (the year ended Dec 31, 2019), against -CA$3.1 million the year before. Source: the 20-F filed with the SEC on Jun 10, 2020. SEC
What was Emerald Health Therapeutics Inc.'s operating income in fiscal 2019?
Emerald Health Therapeutics Inc. reported operating income of -CA$51 million for fiscal 2019 (the year ended Dec 31, 2019), against -CA$37.3 million the year before. Source: the 20-F filed with the SEC on Jun 10, 2020. SEC
What was Emerald Health Therapeutics Inc.'s net income in fiscal 2019?
Emerald Health Therapeutics Inc. reported net income of CA$111.1 million for fiscal 2019 (the year ended Dec 31, 2019), against CA$30.6 million the year before (+263.5%). Source: the 20-F filed with the SEC on Jun 10, 2020. SEC
What was Emerald Health Therapeutics Inc.'s cash from operating activities in fiscal 2019?
Emerald Health Therapeutics Inc. reported cash from operating activities of -CA$24.8 million for fiscal 2019 (the year ended Dec 31, 2019), against -CA$29.1 million the year before. Source: the 20-F filed with the SEC on Jun 10, 2020. SEC
What was Emerald Health Therapeutics Inc.'s free cash flow in fiscal 2019?
Emerald Health Therapeutics Inc. reported free cash flow of -CA$48.9 million for fiscal 2019 (the year ended Dec 31, 2019), against -CA$46.3 million the year before. Source: the 20-F filed with the SEC on Jun 10, 2020. SEC
What are Emerald Health Therapeutics Inc.'s total assets?
As of Dec 31, 2019, Emerald Health Therapeutics Inc. reported total assets of CA$156.6 million, against CA$207 million a year earlier (-24.3%). Source: the 20-F filed with the SEC on Jun 10, 2020. SEC
What are Emerald Health Therapeutics Inc.'s total liabilities?
As of Dec 31, 2019, Emerald Health Therapeutics Inc. reported total liabilities of CA$53.5 million, against CA$36.5 million a year earlier (+46.6%). Source: the 20-F filed with the SEC on Jun 10, 2020. SEC
What are Emerald Health Therapeutics Inc.'s cash and cash equivalents?
As of Dec 31, 2019, Emerald Health Therapeutics Inc. reported cash and cash equivalents of CA$2.5 million, against CA$36 million a year earlier (-93%). Source: the 20-F filed with the SEC on Jun 10, 2020. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1768225&period_type=annual&limit=5"

Information only, not investment advice.